Explore more publications!

Technology Journal of Ohio: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Journal of Ohio.

Press releases published on May 1, 2026

1X、カリフォルニア州ヘイワードにNEOファクトリーを開設、米国初の垂直統合型ヒューマノイドロボット向上から、2026年の一般向け出荷を計画
Intuitive Machines Announces Date for First Quarter 2026 Financial Results Conference Call
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pelthos Therapeutics to Report First Quarter 2026 Financial Results on May 14, 2026
Jet.AI Announces SEC Effectiveness of flyExclusive’s Registration Statement on Form S-4 in Connection with Proposed Merger
Inspira Secures $596,000 AME System Order from Leading Irish Technological University
Inuvo Announces Nomination of Sanja Partalo to Board as Company Prioritizes IntentKey AI Commercial Integrations
Bel Fuse Announces Upcoming Conference Schedule for May 2026
InVitria Showcases Exbumin® and Optibumin® 25 at IPEC Excipient World: Biologics Summit: Recombinant Human Serum Albumins Already Used in On-Market Approved Biologics
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Rezolve Ai’s SQD Token Goes Live on Revolut, Opening Access to 70 Million+ Users Globally
reAlpha (Nasdaq: AIRE) CEO and CFO to Present Company's Vertically Integrated Homebuying Vision at Two New York Conferences
Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
WRAP® Expands Domestic Adoption of Non-Lethal Response™ Solutions with Purchase Order from Carolina Beach Police Department
Vaxart to Host Stockholder Fireside Chat on May 8 at 4:30 p.m. ET
Tower Rush Game UK 2026: 1Win Launched Tower Rush Game App
Traliant Appoints Evan Kramer as Chief Executive Officer to Accelerate Next Phase of Innovation in HR Compliance
InflaRx to Report First Quarter 2026 Results on May 7, 2026
Spirit Blockchain Capital Inc. Files 2025 Audited Financial Statements and Provides Corporate Update
Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions